Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06601049
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
None
First Post:
2024-09-04
Brief Title:
Effectiveness of ResArgin on Adults Body Composition and Health
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Effectiveness of ResArgin on Adults Body Composition and Health a Randomized Double-Blind Placebo-Controlled Trial
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to learn if the supplement ResArgin a reservatrol-based supplement works to slow down muscle loss during a period of fat loss Other related health outcomes such as sleep mood and activity will be assessed The main questions it aims to answer are
Does ResArgin improve muscle loss Does ResArgin improve sleep quality activity mood and body satisfaction
Researchers will compare ResArgin to a placebo a look-alike substance that contains no active ingredients to see if ResArgin works to improve muscle loss and related health outcomes
Participants will
Take ResArgin or the Placebo every day for 3 months
Assessment will occur at Baseline Day 30 Day 60 and Day 90
Participants will complete a daily diary of their mood and health
Does ResArgin improve muscle loss Does ResArgin improve sleep quality activity mood and body satisfaction
Researchers will compare ResArgin to a placebo a look-alike substance that contains no active ingredients to see if ResArgin works to improve muscle loss and related health outcomes
Participants will
Take ResArgin or the Placebo every day for 3 months
Assessment will occur at Baseline Day 30 Day 60 and Day 90
Participants will complete a daily diary of their mood and health
Detailed Description:
Study Purpose Examine the effectiveness of ResArgin in attenuating muscle loss during a period of fat loss in overweight and mildly obese men and women
Outcomes Primary outcomes will be body composition Secondary outcomes will be physical activity food cravings health-related quality of life body satisfaction basal metabolic rate sleep behaviors mood anxiety and perceived stress
Study Design Randomized double-blind placebo-controlled trial
o N 60 men and women 30 adults in the ResArgin Condition and 30 adults in the Placebo Condition
Outcomes Primary outcomes will be body composition Secondary outcomes will be physical activity food cravings health-related quality of life body satisfaction basal metabolic rate sleep behaviors mood anxiety and perceived stress
Study Design Randomized double-blind placebo-controlled trial
o N 60 men and women 30 adults in the ResArgin Condition and 30 adults in the Placebo Condition
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None